Henry A. Nasrallah, MD

Gebhardt, Susanna; Nasrallah, Henry A 2023. The role of the insula in cognitive impairment of schizophrenia. Schizophrenia research. Cognition, 32 , 100277

Kwok, Wan Y; Stephens, Victoria; Nasrallah, Henry A 2023. High-dose armodafinil in treatment-refractory bipolar depression. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 35 3, 195-198

Nasrallah, Henry A 2023. Is preventing the second psychotic episode a disease-modifying strategy for schizophrenia? Schizophrenia research, 252 , 326-328

Nasrallah, Henry A; Keshavan, Matcheri 2023. Controversies and knowledge expansion in psychiatry. Asian journal of psychiatry, 82 , 103535

Tripathi, Ashutosh; Nasrallah, Henry A; Pillai, Anilkumar 2023. Pimavanserin treatment increases plasma brain-derived neurotrophic factor levels in rats. Frontiers in neuroscience, 17 , 1237726

Goldberg, Joseph F; Nasrallah, Henry A 2022. Major depression is a serious and potentially fatal brain syndrome requiring pharmacotherapy or neuromodulation, and psychotherapy. Psychological medicine, 52 8, 1423-1425

Nasrallah, Henry A 2022. Re-inventing the schizophrenia syndrome: The elusive "theory of everything". Schizophrenia research, 242 , 106-108

Nocera, Annamarie; Nasrallah, Henry A 2022. The Association of the Gut Microbiota with Clinical Features in Schizophrenia. Behavioral sciences (Basel, Switzerland), 12 4,

Serafini, Gianluca; Nasrallah, Henry A; Amore, Mario 2022. The use of modern dopamine partial agonists in bipolar depression: is the evidence sound? Current medical research and opinion, 38 5, 773-775

Aboraya, Ahmed; Nasrallah, Henry A; Elswick, Daniel; Rastgar, Yasha; Berry, James; Hill, Cheryl; Justice, John; Zheng, Wanhong; Pearson, Nathan; Gallucci, Gerard; Figgs, Patricia; Hustead, Jeremy; Vogt, Joel; Zafar, Jawad; Dohar, Sheena; Looper, Robert; Guinan, Danielle; Elawady, Akram; Shah, Omar; Lam, Mei Wai; Shagufta, Shanila; Schwartzman, Noah; Hamric, Eddie; Mayle, Lauren; Miller, Mark; Chandran, Dilip; Marshalek, Patrick; Moreland, Rachel; Tamang, Tenchee Lama; Mattancheril, Sunny; Berzingi, Sara 2021. Measurement-based care training curriculum in psychiatry residency programs: I: Description of the curriculum and demonstration of implementation. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 33 3, 168-179

Nasrallah, Henry A 2021. Re-inventing the DSM as a transdiagnostic model: Psychiatric disorders are extensively interconnected. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 33 3, 148-150

Nasrallah, Henry A 2021. The pro- and con-debate about the at-risk state and early intervention: A commentary. Schizophrenia research, 227 , 18-19

Nasrallah, Henry A 2021. To change the label of schizophrenia, first revise the construct. Schizophrenia research, 238 , 201-202

Nasrallah, Henry A; Weiden, Peter J; Walling, David P; Du, Yangchun; Yao, Baiyun; Yagoda, Sergey; Claxton, Amy 2021. Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study. BMC psychiatry, 21 1, 492

Sagarwala, Raza; Nasrallah, Henry A 2021. The effect of antipsychotic medications on white matter integrity in first-episode drug-naïve patients with psychosis: A review of DTI studies. Asian journal of psychiatry, 61 , 102688

Sagarwala, Raza; Nasrallah, Henry A 2020. White matter pathology in patients with borderline personality disorder: A review of controlled DTI studies. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 32 4, 281-286

Sagarwala, Raza; Nasrallah, Henry A 2020. The effects of yoga on depression and motor function in patients with Parkinson's disease: A review of controlled studies. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 32 3, 209-215

Sagarwala, Raza; Nasrallah, Henry A 2020. A systematic review of diffusion tensor imaging studies in drug-naïve OCD patients before and after pharmacotherapy. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 32 1, 42-47

Cannon, Cornita; Nasrallah, Henry A 2019. A focus on postpartum depression among African American women: A literature review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 31 2, 138-143

Chen, Alexander T; Nasrallah, Henry A 2019. Neuroprotective effects of the second generation antipsychotics. Schizophrenia research, 208 , 1-7

Douglas, Jasmine; Nasrallah, Henry A 2019. Low high-density lipoprotein and psychopathology: A review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 31 3, 209-213

Kahlon, Chanchal K; Nasrallah, Henry A 2019. Bidirectional relationship between transient ischemic attacks and depression: A review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 31 3, 214-220

Nasrallah, Henry A; Aquila, Ralph; Du, Yangchun; Stanford, Arielle D; Claxton, Amy; Weiden, Peter J 2019. Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia. CNS spectrums, 24 4, 395-403

Nasrallah, Henry A; Fedora, Rissa; Morton, Robert 2019. Successful treatment of clozapine-nonresponsive refractory hallucinations and delusions with pimavanserin, a serotonin 5HT-2A receptor inverse agonist. Schizophrenia research, 208 , 217-220

Sagarwala, Raza; Nasrallah, Henry A 2019. Changes in inflammatory biomarkers before and after SSRI therapy in PTSD: A review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 31 4, 292-297

Aboraya, Ahmed; Nasrallah, Henry A; Elswick, Daniel E; Ahmed, Elshazly; Estephan, Nevine; Aboraya, Dalia; Berzingi, Seher; Chumbers, Josleen; Berzingi, Sara; Justice, John; Zafar, Jawad; Dohar, Sheena 2018. Measurement-based Care in Psychiatry-Past, Present, and Future. Innovations in clinical neuroscience, 15 11-12, 13-26

Adams, Selin A; Nasrallah, Henry A 2018. Multiple retinal anomalies in schizophrenia. Schizophrenia research, 195 , 3-12

Chen, Alexander T; Malmstrom, Theodore; Nasrallah, Henry A 2018. Body temperature rises following improvement of depression with ECT. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 30 3, 196-199

Chen, Alexander T; Malmstrom, Theodore; Nasrallah, Henry A 2018. Allopurinol augmentation in acute mania: A meta-analysis of placebo-controlled trials. Journal of affective disorders, 226 , 245-250

Citrome, Leslie; Risinger, Robert; Cutler, Andrew J; Du, Yangchun; Zummo, Jacqueline; Nasrallah, Henry A; Silverman, Bernard L 2018. Effect of aripiprazole lauroxil in patients with acute schizophrenia as assessed by the Positive and Negative Syndrome Scale-supportive analyses from a Phase 3 study. CNS spectrums, 23 4, 284-290

Durgam, Suresh; Earley, Willie; Li, Rui; Li, Dayong; Lu, Kaifeng; Laszlovszky, István; Wolfgang Fleischhacker, W; Nasrallah, Henry A 2018. Corrigendum to "Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial" [Schizophr. Res. 176 (2016) 264-271]. Schizophrenia research, 192 , 493

Khoury, Rita; Nasrallah, Henry A 2018. Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait? Schizophrenia research, 199 , 31-38

Lu, Syshane; Nasrallah, Henry A 2018. The use of memantine in neuropsychiatric disorders: An overview. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 30 3, 234-248

Nasrallah, Henry A 2018. Triple advantages of injectable long acting second generation antipsychotics: Relapse prevention, neuroprotection, and lower mortality. Schizophrenia research, 197 , 69-70

Sagarwala, Raza; Malmstrom, Theodore; Nasrallah, Henry A 2018. Effects of nonpharmacological therapies on anxiety and cortisol: A meta-analysis. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 30 2, 91-96

Aboraya, Ahmed; Leucht, Stefan; Nasrallah, Henry A; Samara, Myrto; Haro, Josep Maria; Elshazly, Ahmed; Zangeneh, Masood 2017. A novel approach to measuring response and remission in schizophrenia in clinical trials. Schizophrenia research, 190 , 123-128

Blanchard, Jack J; Bradshaw, Kristen R; Garcia, Cristina P; Nasrallah, Henry A; Harvey, Philip D; Casey, Daniel; Csoboth, Csilla T; Hudson, James I; Julian, Laura; Lentz, Ellen; Nuechterlein, Keith H; Perkins, Diana O; Skale, Tracey G; Snowden, Lonnie R; Tandon, Rajiv; Tek, Cenk; Velligan, Dawn; Vinogradov, Sophia; O'Gorman, Cedric 2017. Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study. Schizophrenia research, 185 , 137-143

Durgam, Suresh; Landbloom, Ronald P; Mackle, Mary; Wu, Xiao; Mathews, Maju; Nasrallah, Henry A 2017. Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study. Neuropsychiatric disease and treatment, 13 , 2021-2035

Keshavan, Matcheri S; DeLisi, Lynn E; Nasrallah, Henry A 2017. Translational and spectrum aspects of Schizophrenia Research: The rationale for new journal's new subheading. Schizophrenia research, 179 , 1

Keshavan, Matcheri S; Lawler, Ashley N; Nasrallah, Henry A; Tandon, Rajiv 2017. New drug developments in psychosis: Challenges, opportunities and strategies. Progress in neurobiology, 152 , 3-20

Nasrallah, Henry A; Aquila, Ralph; Stanford, Arielle D; Jamal, Hasan H; Weiden, Peter J; Risinger, Robert 2017. Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil. Psychopharmacology bulletin, 47 3, 35-43

Nasrallah, Henry A; Chen, Alexander T 2017. Multiple neurotoxic effects of haloperidol resulting in neuronal death. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 29 3, 195-202

Nasrallah, Henry A; Earley, Willie; Cutler, Andrew J; Wang, Yao; Lu, Kaifeng; Laszlovszky, István; Németh, György; Durgam, Suresh 2017. The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis. BMC psychiatry, 17 1, 305

Upadhyaya, Mihir A; Nasrallah, Henry A 2017. The intense desire for healthy limb amputation: A dis-proprioceptive neuropsychiatric disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 29 2, 125-132

Aboraya, Ahmed; Nasrallah, Henry A 2016. Perspectives on the Positive and Negative Syndrome Scale (PANSS): Use, misuse, drawbacks, and a new alternative for schizophrenia research. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 28 2, 125-31

Alphs, Larry; Nasrallah, Henry A; Bossie, Cynthia A; Fu, Dong-Jing; Gopal, Srihari; Hough, David; Turkoz, Ibrahim 2016. Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy. International clinical psychopharmacology, 31 4, 202-9

Chen, Alexander T; Chibnall, John T; Nasrallah, Henry A 2016. Placebo-controlled augmentation trials of the antioxidant NAC in schizophrenia: A review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 28 3, 190-6

Durgam, Suresh; Earley, Willie; Li, Rui; Li, Dayong; Lu, Kaifeng; Laszlovszky, István; Fleischhacker, W Wolfgang; Nasrallah, Henry A 2016. Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial. Schizophrenia research, 176 2-3, 264-271

Gondim, Francisco de Assis Aquino; Thomas, Florian P; Cruz-Flores, Salvador; Nasrallah, Henry A; Selhorst, John B 2016. Pathological laughter and crying: A case series and proposal for a new classification. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 28 1, 11-21

Nasrallah, Henry A 2016. A Valedictory from the Founding Editors. Schizophrenia research, 175 1-3, 1

Nasrallah, Henry A; Newcomer, John W; Risinger, Robert; Du, Yangchun; Zummo, Jacqueline; Bose, Anjana; Stankovic, Srdjan; Silverman, Bernard L; Ehrich, Elliot W 2016. Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia. The Journal of clinical psychiatry, 77 11, 1519-1525

Yum, Sun Young; Hwang, Michael Y; Nasrallah, Henry A; Opler, Lewis A 2016. Transcending Psychosis: The Complexity of Comorbidity in Schizophrenia. The Psychiatric clinics of North America, 39 2, 267-74

Chen, Alexander T; Chibnall, John T; Nasrallah, Henry A 2015. A meta-analysis of placebo-controlled trials of omega-3 fatty acid augmentation in schizophrenia: Possible stage-specific effects. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 27 4, 289-96

Lawson, William; Johnston, Stephen; Karson, Craig; Offord, Steve; Docherty, John; Eramo, Anna; Kamat, Siddhesh; Blanchette, Christopher M; Carson, William; Nasrallah, Henry A 2015. Racial differences in antipsychotic use: Claims database analysis of Medicaid-insured patients with schizophrenia. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 27 4, 242-52

Meltzer, Herbert Y; Risinger, Robert; Nasrallah, Henry A; Du, Yangchun; Zummo, Jacqueline; Corey, Lisa; Bose, Anjana; Stankovic, Srdjan; Silverman, Bernard L; Ehrich, Elliot W 2015. A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia. The Journal of clinical psychiatry, 76 8, 1085-90

Nasrallah, Henry A 2015. Toward the era of transformational neuropsychiatry. Asian journal of psychiatry, 17 , 140-1

Nasrallah, Henry A 2015. Consequences of misdiagnosis: inaccurate treatment and poor patient outcomes in bipolar disorder. The Journal of clinical psychiatry, 76 10, e1328

Nasrallah, Henry A; Cucchiaro, Josephine B; Mao, Yongcai; Pikalov, Andrei A; Loebel, Antony D 2015. Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies. CNS spectrums, 20 2, 140-7

Nasrallah, Henry A; Harvey, Philip D; Casey, Daniel; Csoboth, Csilla T; Hudson, James I; Julian, Laura; Lentz, Ellen; Nuechterlein, Keith H; Perkins, Diana O; Kotowsky, Nirali; Skale, Tracey G; Snowden, Lonnie R; Tandon, Rajiv; Tek, Cenk; Velligan, Dawn; Vinogradov, Sophia; O'Gorman, Cedric 2015. The Management of Schizophrenia in Clinical Practice (MOSAIC) Registry: a focus on patients, caregivers, illness severity, functional status, disease burden and healthcare utilization. Schizophrenia research, 166 1-3, 69-79

Schooler, Nina R; Buchanan, Robert W; Laughren, Thomas; Leucht, Stefan; Nasrallah, Henry A; Potkin, Steven G; Abi-Saab, Danielle; Berardo, Carmen Galani; Bugarski-Kirola, Dragana; Blaettler, Thomas; Edgar, Chris J; Nordstroem, Anna-Lena; O'Gorman, Cedric; Garibaldi, George 2015. Defining therapeutic benefit for people with schizophrenia: focus on negative symptoms. Schizophrenia research, 162 1-3, 169-74

Serafini, Gianluca; Gonda, Xenia; Rihmer, Zoltan; Pompili, Maurizio; Girardi, Paolo; Nasrallah, Henry A; Amore, Mario 2015. NMDA receptor antagonists for depression: Critical considerations. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 27 3, 213-20

Park, Sohee; Nasrallah, Henry A 2014. The varieties of anomalous self experiences in schizophrenia: splitting of the mind at a crossroad. Schizophrenia research, 152 1, 1-4

Keshavan, M S; Tandon, R; Nasrallah, H A 2013. Renaming schizophrenia: keeping up with the facts. Schizophrenia research, 148 1-3, 1-2

McEvoy, Joseph; Baillie, Rebecca A; Zhu, Hongjie; Buckley, Peter; Keshavan, Matcheri S; Nasrallah, Henry A; Dougherty, George G; Yao, Jeffrey K; Kaddurah-Daouk, Rima 2013. Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics. PloS one, 8 7, e68717

Nasrallah, Henry A; Delisi, Lynn E 2013. 25 years of editing Schizophrenia research: a unique and gratifying journey. Schizophrenia research, 143 1, 1-2

Nasrallah, Henry A; Silva, Robert; Phillips, Debra; Cucchiaro, Josephine; Hsu, Jay; Xu, Jane; Loebel, Antony 2013. Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study. Journal of psychiatric research, 47 5, 670-7

Ravyn, Dana; Ravyn, Vipa; Lowney, Robert; Nasrallah, Henry A 2013. CYP450 pharmacogenetic treatment strategies for antipsychotics: a review of the evidence. Schizophrenia research, 149 1-3, 1-14

Stroup, T Scott; Byerly, Matthew J; Nasrallah, Henry A; Ray, Neepa; Khan, Ahsan Y; Lamberti, J Steven; Glick, Ira D; Steinbook, Richard M; McEvoy, Joseph P; Hamer, Robert M 2013. Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial. Schizophrenia research, 146 1-3, 190-5

Watson, A M M; Prasad, K M; Klei, L; Wood, J A; Yolken, R H; Gur, R C; Bradford, L D; Calkins, M E; Richard, J; Edwards, N; Savage, R M; Allen, T B; Kwentus, J; McEvoy, J P; Santos, A B; Wiener, H W; Go, R C P; Perry, R T; Nasrallah, H A; Gur, R E; Devlin, B; Nimgaonkar, V L 2013. Persistent infection with neurotropic herpes viruses and cognitive impairment. Psychological medicine, 43 5, 1023-31

Bamne, Mikhil; Wood, Joel; Chowdari, Kodavali; Watson, Annie M; Celik, Cemil; Mansour, Hader; Klei, Lambertus; Gur, Ruben C; Bradford, L DiAnne; Calkins, Monica E; Santos, Alberto B; Edwards, Neil; Kwentus, Joseph; McEvoy, Joseph P; Allen, Trina B; Savage, Robert M; Nasrallah, Henry A; Gur, Raquel E; Perry, Rodney T; Go, Rodney C P; Devlin, Bernie; Yolken, Robert; Nimgaonkar, Vishwajit L 2012. Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure. Schizophrenia bulletin, 38 6, 1149-54

Citrome, Leslie; Nasrallah, Henry A 2012. On-label on the table: what the package insert informs us about the tolerability profile of oral atypical antipsychotics, and what it does not. Expert opinion on pharmacotherapy, 13 11, 1599-613

Gilday, Elizabeth; Nasrallah, Henry A 2012. Clinical pharmacology of paliperidone palmitate a parenteral long-acting formulation for the treatment of schizophrenia. Reviews on recent clinical trials, 7 1, 2-9

Gohlke, Julia M; Dhurandhar, Emily J; Correll, Christoph U; Morrato, Elaine H; Newcomer, John W; Remington, Gary; Nasrallah, Henry A; Crystal, Stephen; Nicol, Ginger ; Allison, David B 2012. Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs. Frontiers in psychiatry, 3 , 62

Hudepohl, Neha S; Nasrallah, Henry A 2012. Antipsychotic drugs. Handbook of clinical neurology, 106 , 657-67

Kaddurah-Daouk, Rima; McEvoy, Joseph; Baillie, Rebecca; Zhu, Hongjie; K Yao, Jeffrey; Nimgaonkar, Vishwajit L; Buckley, Peter F; Keshavan, Matcheri S; Georgiades, Anastasia; Nasrallah, Henry A 2012. Impaired plasmalogens in patients with schizophrenia. Psychiatry research, 198 3, 347-52

Nasrallah, Henry A 2012. Does the neurotoxicity of haloperidol explain the higher mortality in dementia patients compared with the second generation agents? The American journal of psychiatry, 169 6, 663-4; author reply

Jameson, Kathryn G; Nasrallah, Henry A; Northern, Tracie G; Welge, Jeffrey A 2011. Executive function impairment in first-degree relatives of persons with schizophrenia: A meta-analysis of controlled studies. Asian journal of psychiatry, 4 2, 96-9

Keshavan, Matcheri S; Nasrallah, Henry A; Tandon, Rajiv 2011. Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse. Schizophrenia research, 127 1-3, 3-13

Tandon, Rajiv; Nasrallah, Henry A; Keshavan, Matcheri S 2011. "Just the facts": meandering in schizophrenia's many forests. Schizophrenia research, 128 1-3, 5-6

Devulapalli, Kavi; Nasrallah, Henry A 2010. Schizophrenia and obsessive-compulsive disorder. The American journal of psychiatry, 167 11, 1407-8

Nasrallah, Henry A 2010. Linkage of cognitive impairments with metabolic disorders in schizophrenia. The American journal of psychiatry, 167 10, 1155-7

Nasrallah, Henry A; Goldberg, Joseph F; Correll, Cristoph U 2010. Differential diagnosis and therapeutic management of schizoaffective disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 22 4 Suppl 1, S1-12

Nasrallah, Henry A; Gopal, Srihari; Gassmann-Mayer, Cristiana; Quiroz, Jorge A; Lim, Pilar; Eerdekens, Mariëlle; Yuen, Eric; Hough, David 2010. A controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic, in schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 35 10, 2072-82

Nasrallah, Henry A; Hopkins, Tracy; Pixley, Sarah K 2010. Differential effects of antipsychotic and antidepressant drugs on neurogenic regions in rats. Brain research, 1354 , 23-9

Shertzer, H G; Kendig, E L; Nasrallah, H A; Johansson, E; Genter, M B 2010. Protection from olanzapine-induced metabolic toxicity in mice by acetaminophen and tetrahydroindenoindole. International journal of obesity (2005), 34 6, 970-9

Tandon, Rajiv; Nasrallah, Henry A; Keshavan, Matcheri S 2010. Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future. Schizophrenia research, 122 1-3, 1-23

Danielyan, Arman; Nasrallah, Henry A 2009. Neurological disorders in schizophrenia. The Psychiatric clinics of North America, 32 4, 719-57

Devulapalli, Kavi K; Nasrallah, Henry A 2009. An analysis of the high psychotropic off-label use in psychiatric disorders The majority of psychiatric diagnoses have no approved drug. Asian journal of psychiatry, 2 1, 29-36

Hwang, Michael Y; Nasrallah, Henry A 2009. Psychiatric and physical comorbidity in schizophrenia. Preface. The Psychiatric clinics of North America, 32 4, xiii-xv

Meyer, Jonathan M; McEvoy, Joseph P; Davis, Vicki G; Goff, Donald C; Nasrallah, Henry A; Davis, Sonia M; Hsiao, John K; Swartz, Marvin S; Stroup, T Scott; Lieberman, Jeffrey A 2009. Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study. Biological psychiatry, 66 11, 1013-22

Nasrallah, Henry A 2009. Meta-analysis trends in schizophrenia over three decades. Schizophrenia research, 108 1-3, 1-2

Nasrallah, Henry A; Keshavan, Matcheri S; Benes, Francine M; Braff, David L; Green, Alan I; Gur, Raquel E; Kane, John M; Perkins, Diana O; Weiden, Peter J; Weinberger, Daniel R; Correll, Christoph U 2009. Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia. The Journal of clinical psychiatry, 70 Suppl 1 , 4-46

Tandon, Rajiv; Nasrallah, Henry A; Keshavan, Matcheri S 2009. Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophrenia research, 110 1-3, 1-23

Wiener, H W; Klei, L; Irvin, M D; Perry, R T; Aliyu, M H; Allen, T B; Bradford, L D; Calkins, M E; Devlin, B; Edwards, N; Gur, R E; Gur, R C; Kwentus, J; Lyons, P D; McEvoy, J P; Nasrallah, H A; Nimgaonkar, V L; O'Jile, J; Santos, A B; Savage, R M; Go, R C P 2009. Linkage analysis of schizophrenia in African-American families. Schizophrenia research, 109 1-3, 70-9

Ali-Shtayeh, Mohammed S; Jamous, Rana M; Al-Shafie', Jehan H; Elgharabah, Wafa' A; Kherfan, Fatemah A; Qarariah, Kifayeh H; Khdair, Isra' S; Soos, Israa M; Musleh, Aseel A; Isa, Buthainah A; Herzallah, Hanan M; Khlaif, Rasha B; Aiash, Samiah M; Swaiti, Ghadah M; Abuzahra, Muna A; Haj-Ali, Maha M; Saifi, Nehaya A; Azem, Hebah K; Nasrallah, Hanadi A 2008. Traditional knowledge of wild edible plants used in Palestine (Northern West Bank): a comparative study. Journal of ethnobiology and ethnomedicine, 4 , 13

Daumit, Gail L; Goff, Donald C; Meyer, Jonathan M; Davis, Vicki G; Nasrallah, Henry A; McEvoy, Joseph P; Rosenheck, Robert; Davis, Sonia M; Hsiao, John K; Stroup, T Scott; Lieberman, Jeffrey A 2008. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophrenia research, 105 1-3, 175-87

DeLisi, Lynn E; Nasrallah, Henry A 2008. Celebrating twenty years of schizophrenia research. Schizophrenia research, 100 1-3, 1-3

Devulapalli, Kavi K; Welge, Jeffrey A; Nasrallah, Henry A 2008. Temporal sequence of clinical manifestation in schizophrenia with co-morbid OCD: review and meta-analysis. Psychiatry research, 161 1, 105-8

Keshavan, Matcheri S; Tandon, Rajiv; Boutros, Nash N; Nasrallah, Henry A 2008. Schizophrenia, "just the facts": what we know in 2008 Part 3: neurobiology. Schizophrenia research, 106 2-3, 89-107

Meyer, Jonathan M; Davis, Vicki G; Goff, Donald C; McEvoy, Joseph P; Nasrallah, Henry A; Davis, Sonia M; Rosenheck, Robert A; Daumit, Gail L; Hsiao, John; Swartz, Marvin S; Stroup, T Scott; Lieberman, Jeffrey A 2008. Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1. Schizophrenia research, 101 1-3, 273-86

Meyer, Jonathan M; Davis, Vicki G; McEvoy, Joseph P; Goff, Donald C; Nasrallah, Henry A; Davis, Sonia M; Daumit, Gail L; Hsiao, John; Swartz, Marvin S; Stroup, T Scott; Lieberman, Jeffrey A 2008. Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1. Schizophrenia research, 103 1-3, 104-9

Nasrallah, H A 2008. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Molecular psychiatry, 13 1, 27-35

Nasrallah, Henry A 2008. The urgent need for monitoring and intervention to reduce metabolic risk factors in patients with schizophrenia. CNS spectrums, 13 6 Suppl 10, 5-6

Nasrallah, Henry A; Black, Donald W; Goldberg, Joseph F; Muzina, David J; Pariser, Stephen F 2008. Diagnosing and managing psychotic and mood disorders. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 20 Suppl 1 , S1-28; quiz S29-30

Newcomer, John W; Nasrallah, Henry A; McIntyre, Roger S; McIntyre, Roger S; Vogel-Scibilia, Suzanne 2008. Elevating the standard of care in the management of cardiometabolic risk factors in patients with mental illness. Conclusion: summary and recommendations. CNS spectrums, 13 6 Suppl 10, 13-4

Tandon, Rajiv; Keshavan, Matcheri S; Nasrallah, Henry A 2008. Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophrenia research, 102 1-3, 1-18

Tandon, Rajiv; Keshavan, Matcheri S; Nasrallah, Henry A 2008. Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview. Schizophrenia research, 100 1-3, 4-19

Cerullo, Michael A; Adler, Caleb M; Strakowski, Stephen M; Eliassen, James C; Nasrallah, Henry A; Nasrallah, Amelia T 2007. Memantine normalizes brain activity in the inferior frontal gyrus: a controlled pilot fMRI study. Schizophrenia research, 97 1-3, 294-6

Dlugosz, Heather; Nasrallah, Henry A 2007. Paliperidone: a new extended-release oral atypical antipsychotic. Expert opinion on pharmacotherapy, 8 14, 2307-13

Nasrallah, H A 2007. The case for long-acting antipsychotic agents in the post-CATIE era. Acta psychiatrica Scandinavica, 115 4, 260-7

Nasrallah, Henry A 2007. The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial. The Journal of clinical psychiatry, 68 Suppl 1 , 5-11

Nasrallah, Henry A 2007. Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond. The Journal of clinical psychiatry, 68 Suppl 1 , 3-4

Ketter, Terence A; Nasrallah, Henry A; Fagiolini, Andrea 2006. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder. Psychopharmacology bulletin, 39 1, 120-46

Nasrallah, Henry A 2006. Metabolic findings from the CATIE trial and their relation to tolerability. CNS spectrums, 11 7 Suppl 7, 32-9

Nasrallah, Henry A; Brecher, Martin; Paulsson, Björn 2006. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania. Bipolar disorders, 8 5 Pt 1, 467-74

Nasrallah, Henry A; Dursun, Serdar M 2006. Raising the bar for treatment expectations in schizophrenia: achieving remission as a routine goal of antipsychotic pharmacotherapy. Journal of psychopharmacology (Oxford, England), 20 6 Suppl, 3-5

Nasrallah, Henry A; Ketter, Terence A; Kalali, Amir H 2006. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature. Journal of affective disorders, 95 1-3, 69-78

Nasrallah, Henry A; Lasser, Rob 2006. Improving patient outcomes in schizophrenia: achieving remission. Journal of psychopharmacology (Oxford, England), 20 6 Suppl, 57-61

Nasrallah, Henry A; Meyer, Jonathan M; Goff, Donald C; McEvoy, Joseph P; Davis, Sonia M; Stroup, T Scott; Lieberman, Jeffrey A 2006. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophrenia research, 86 1-3, 15-22

Singh, Manpreet K; Giles, Lisa L; Nasrallah, Henry A 2006. Pain insensitivity in schizophrenia: trait or state marker? Journal of psychiatric practice, 12 2, 90-102

Tandon, Rajiv; Nasrallah, Henry A 2006. Subjecting meta-analyses to closer scrutiny: Little support for differential efficacy among second-generation antipsychotics at equivalent doses. Archives of general psychiatry, 63 8, 935-7; author reply

Tandon, Rajiv; Targum, Steven D; Nasrallah, Henry A; Ross, Ruth 2006. Strategies for maximizing clinical effectiveness in the treatment of schizophrenia. Journal of psychiatric practice, 12 6, 348-63

Terry, Alvin V; Parikh, Vinay; Gearhart, Debra A; Pillai, Anilkumar; Hohnadel, Elizabeth; Warner, Samantha; Nasrallah, Henry A; Mahadik, Sahebarao P 2006. Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats. The Journal of pharmacology and experimental therapeutics, 318 2, 709-24

Delisi, L E; Nasrallah, H A 2005. The CATIE schizophrenia effectiveness trial. Schizophrenia research, 80 1, v-vi

Goff, Donald C; Sullivan, Lisa M; McEvoy, Joseph P; Meyer, Jonathan M; Nasrallah, Henry A; Daumit, Gail L; Lamberti, Steven; D'Agostino, Ralph B; Stroup, Thomas S; Davis, Sonia; Lieberman, Jeffrey A 2005. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia research, 80 1, 45-53

McEvoy, Joseph P; Meyer, Jonathan M; Goff, Donald C; Nasrallah, Henry A; Davis, Sonia M; Sullivan, Lisa; Meltzer, Herbert Y; Hsiao, John; Scott Stroup, T; Lieberman, Jeffrey A 2005. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia research, 80 1, 19-32

Meyer, Jonathan M; Nasrallah, Henry A; McEvoy, Joseph P; Goff, Donald C; Davis, Sonia M; Chakos, Miranda; Patel, Jayendra K; Keefe, Richard S E; Stroup, T Scott; Lieberman, Jeffrey A 2005. The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. Schizophrenia research, 80 1, 9-18

Nasrallah, Henry A 2005. Neurologic comorbidities in schizophrenia. The Journal of clinical psychiatry, 66 Suppl 6 , 34-46

Nasrallah, Henry A 2005. An overview of common medical comorbidities in patients with schizophrenia. The Journal of clinical psychiatry, 66 Suppl 6 , 3-4

Nasrallah, Henry A; Targum, Steven D; Tandon, Rajiv; McCombs, Jeffrey S; Ross, Ruth 2005. Defining and measuring clinical effectiveness in the treatment of schizophrenia. Psychiatric services (Washington, D.C.), 56 3, 273-82

Keith, Samuel J; Kane, John M; Turner, Martin; Conley, Robert R; Nasrallah, Henry A 2004. Academic highlights: guidelines for the use of long-acting injectable atypical antipsychotics. The Journal of clinical psychiatry, 65 1, 120-31

Lasser, Robert; Bossie, Cynthia A; Gharabawi, Georges; Eerdekens, Marielle; Nasrallah, Henry A 2004. Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder. Journal of affective disorders, 83 2-3, 263-75

Menon, P Mohanakrishnan; Nasrallah, Henry A; Reeves, Roy R; Ali, Jeffrey A 2004. Hippocampal dysfunction in Gulf War Syndrome. A proton MR spectroscopy study. Brain research, 1009 1-2, 189-94

Mittal, Dinesh; Jimerson, Nita A; Neely, Emily P; Johnson, William D; Kennedy, Richard E; Torres, Rafael A; Nasrallah, Henry A 2004. Risperidone in the treatment of delirium: results from a prospective open-label trial. The Journal of clinical psychiatry, 65 5, 662-7

Nasrallah, Henry A; Duchesne, Inge; Mehnert, Angelika; Janagap, Carmela; Eerdekens, Mariëlle 2004. Health-related quality of life in patients with schizophrenia during treatment with long-acting, injectable risperidone. The Journal of clinical psychiatry, 65 4, 531-6

Nasrallah, Henry A; Newcomer, John W 2004. Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care. Journal of clinical psychopharmacology, 24 5 Suppl 1, S7-14

Newcomer, John W; Nasrallah, Henry A; Loebel, Antony D 2004. The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: practice patterns and knowledge of psychiatrists. Journal of clinical psychopharmacology, 24 5 Suppl 1, S1-6

Gianfrancesco, Frank; White, Richard; Wang, Ruey-hua; Nasrallah, Henry A 2003. Antipsychotic-induced type 2 diabetes: evidence from a large health plan database. Journal of clinical psychopharmacology, 23 4, 328-35

Mohanakrishnan Menon, P; Nasrallah, Henry A; Lyons, Judith A; Scott, Mertis F; Liberto, Vincent 2003. Single-voxel proton MR spectroscopy of right versus left hippocampi in PTSD. Psychiatry research, 123 2, 101-8

Möller, Hans-Jürgen; Nasrallah, Henry A 2003. Treatment of bipolar disorder. The Journal of clinical psychiatry, 64 Suppl 6 , 9-17; discussion 28

Nasrallah, Hassan A; Balling, Robert C; Madi, Shaker Mohammed; Al-Ansari, Lamya 2003. Temporal variations in atmospheric CO2 concentrations in Kuwait City, Kuwait with comparisons to Phoenix, Arizona, USA. Environmental pollution (Barking, Essex : 1987), 121 2, 301-5

Nasrallah, Henry A 2003. Factors in antipsychotic drug selection: tolerability considerations. CNS spectrums, 8 11 Suppl 2, 23-5

Gianfrancesco, Frank D; Grogg, Amy L; Mahmoud, Ramy A; Wang, Ruey-hua; Nasrallah, Henry A 2002. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database. The Journal of clinical psychiatry, 63 10, 920-30

Nasrallah, Henry A 2002. Pharmacoeconomic implications of adverse effects during antipsychotic drug therapy. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 59 22 Suppl 8, S16-21

Nasrallah, Henry A; Tandon, Rajiv 2002. Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia. The Journal of clinical psychiatry, 63 Suppl 13 , 12-20

Nasrallah, H A; Mulvihill, T 2001. Iatrogenic disorders associated with conventional vs. atypical antipsychotics. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 13 4, 215-27

Basso, M R; Nasrallah, H A; Olson, S C; Bornstein, R A 1998. Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia. Schizophrenia research, 31 2-3, 99-111

Niedermier, J A; Nasrallah, H A 1998. Clinical correlates of response to valproate in geriatric inpatients. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 10 4, 165-8

Basso, M R; Nasrallah, H A; Olson, S C; Bornstein, R A 1997. Cognitive deficits distinguish patients with adolescent- and adult-onset schizophrenia. Neuropsychiatry, neuropsychology, and behavioral neurology, 10 2, 107-12

Nasrallah, H A; Sharma, S; Olson, S C 1997. The volume of the entorhinal cortex in schizophrenia: a controlled MRI study. Progress in neuro-psychopharmacology & biological psychiatry, 21 8, 1317-22

Nasrallah, H A; Tolbert, H A 1997. Neurobiology and neuroplasticity in schizophrenia. Continuity across the life cycle. Archives of general psychiatry, 54 10, 913-4

Pariser, S F; Nasrallah, H A; Gardner, D K 1997. Postpartum mood disorders: clinical perspectives. Journal of women's health / the official publication of the Society for the Advancement of Women's Health Research, 6 4, 421-34

Boutros, N N; Torello, M W; Barker, B A; Tueting, P A; Wu, S C; Nasrallah, H A 1995. The P50 evoked potential component and mismatch detection in normal volunteers: implications for the study of sensory gating. Psychiatry research, 57 1, 83-8

Boutros, N; Torello, M W; Burns, E M; Wu, S S; Nasrallah, H A 1995. Evoked potentials in subjects at risk for Alzheimer's disease. Psychiatry research, 57 1, 57-63

Nasrallah, H A 1995. Brain and CSF volume differences in schizophrenic subtypes. The American journal of psychiatry, 152 5, 817; author reply 81

Nasrallah, H A; Balling, R C 1995. Impact of desertification on temperature trends in the Middle East. Environmental monitoring and assessment, 37 1-3, 265-71

Beason-Hazen, S; Nasrallah, H A; Bornstein, R A 1994. Self-report of symptoms and neuropsychological performance in asymptomatic HIV-positive individuals. The Journal of neuropsychiatry and clinical neurosciences, 6 1, 43-9

Bornstein, R A; Nasrallah, H A; Para, M F; Whitacre, C C; Fass, R J 1994. Duration of illness and neuropsychological performance in asymptomatic HIV infection. The Journal of neuropsychiatry and clinical neurosciences, 6 2, 160-4

Nasrallah, H A; Skinner, T E; Schmalbrock, P; Robitaille, P M 1994. Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study. The British journal of psychiatry : the journal of mental science, 165 4, 481-5

Podraza, A M; Bornstein, R A; Whitacre, C C; Para, M F; Fass, R J; Rice, R R; Nasrallah, H A 1994. Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infection. Journal of clinical and experimental neuropsychology, 16 5, 777-83

Bornstein, R A; Fama, R; Rosenberger, P; Whitacre, C C; Para, M F; Nasrallah, H A; Fass, R J 1993. Drug and alcohol use and neuropsychological performance in asymptomatic HIV infection. The Journal of neuropsychiatry and clinical neurosciences, 5 3, 254-9

Bornstein, R A; Nasrallah, H A; Para, M F; Whitacre, C C; Fass, R J 1993. Change in neuropsychological performance in asymptomatic HIV infection: 1-year follow-up. AIDS (London, England), 7 12, 1607-11

Bornstein, R A; Nasrallah, H A; Para, M F; Whitacre, C C; Rosenberger, P; Fass, R J 1993. Neuropsychological performance in symptomatic and asymptomatic HIV infection. AIDS (London, England), 7 4, 519-24

Bornstein, R A; Pace, P; Rosenberger, P; Nasrallah, H A; Para, M F; Whitacre, C C; Fass, R J 1993. Depression and neuropsychological performance in asymptomatic HIV infection. The American journal of psychiatry, 150 6, 922-7

Jurjus, G J; Nasrallah, H A; Brogan, M; Olson, S C 1993. Developmental brain anomalies in schizophrenia and bipolar disorder: a controlled MRI study. The Journal of neuropsychiatry and clinical neurosciences, 5 4, 375-8

Jurjus, G J; Nasrallah, H A; Olson, S C; Schwarzkopf, S B 1993. Cavum septum pellucidum in schizophrenia, affective disorder and healthy controls: a magnetic resonance imaging study. Psychological medicine, 23 2, 319-22

McCoy, L; Votolato, N A; Schwarzkopf, S B; Nasrallah, H A 1993. Clinical correlates of valproate augmentation in refractory bipolar disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 5 1, 29-33

Nasrallah, H A 1993. Neurodevelopmental pathogenesis of schizophrenia. The Psychiatric clinics of North America, 16 2, 269-80

Olson, S C; Bornstein, R A; Schwarzkopf, S B; Nasrallah, H A 1993. Are controls in schizophrenia research "normal"? Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 5 1, 1-5

Bornstein, R A; Chakeres, D; Brogan, M; Nasrallah, H A; Fass, R J; Para, M; Whitacre, C 1992. Magnetic resonance imaging of white matter lesions in HIV infection. The Journal of neuropsychiatry and clinical neurosciences, 4 2, 174-8

Bornstein, R A; Nasrallah, H A; Para, M F; Whitacre, C C; Rosenberger, P; Fass, R J; Rice, R 1992. Neuropsychological performance in asymptomatic HIV infection. The Journal of neuropsychiatry and clinical neurosciences, 4 4, 386-94

Bornstein, R A; Schwarzkopf, S B; Olson, S C; Nasrallah, H A 1992. Third-ventricle enlargement and neuropsychological deficit in schizophrenia. Biological psychiatry, 31 9, 954-61

Bornstein, R A; Nasrallah, H A; Para, M F; Fass, R J; Whitacre, C C; Rice, R R 1991. Rate of CD4 decline and neuropsychological performance in HIV infection. Archives of neurology, 48 7, 704-7

Nasrallah, H A 1991. Progressive and static ventriculomegaly in schizophrenia: clinical and methodological variables. Schizophrenia research, 5 3, 191-2

Nasrallah, H A 1991. Neurodevelopmental aspects of bipolar affective disorder. Biological psychiatry, 29 1, 1-2

Nasrallah, H A; Schwarzkopf, S B; Olson, S C; Coffman, J A 1991. Perinatal brain injury and cerebellar vermal lobules I-X in schizophrenia. Biological psychiatry, 29 6, 567-74

Schwarzkopf, S B; Nasrallah, H A; Olson, S C; Bogerts, B; McLaughlin, J A; Mitra, T 1991. Family history and brain morphology in schizophrenia: an MRI study. Psychiatry research, 40 1, 49-60

Bornstein, R A; Nasrallah, H A; Olson, S C; Coffman, J A; Torello, M; Schwarzkopf, S B 1990. Neuropsychological deficit in schizophrenic subtypes: paranoid, nonparanoid, and schizoaffective subgroups. Psychiatry research, 31 1, 15-24

Coffman, J A; Bornstein, R A; Olson, S C; Schwarzkopf, S B; Nasrallah, H A 1990. Cognitive impairment and cerebral structure by MRI in bipolar disorder. Biological psychiatry, 27 11, 1188-96

Coffman, J A; Torello, M W; Bornstein, R A; Chakeres, D; Burns, E; Nasrallah, H A 1990. Leukoaraiosis in asymptomatic adult offspring of individuals with Alzheimer's disease. Biological psychiatry, 27 11, 1244-8

Nasrallah, H A; Schwarzkopf, S B; Olson, S C; Coffman, J A 1990. Gender differences in schizophrenia on MRI brain scans. Schizophrenia bulletin, 16 2, 205-10

Paulman, R G; Devous, M D; Gregory, R R; Herman, J H; Jennings, L; Bonte, F J; Nasrallah, H A; Raese, J D 1990. Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function. Biological psychiatry, 27 4, 377-99

Schwarzkopf, S B; Lamberti, J S; Jiminez, M; Kane, C F; Henricks, M; Nasrallah, H A 1990. Visual evoked potential correlates of positive/negative symptoms in schizophrenia. Biological psychiatry, 27 4, 400-10

Schwarzkopf, S B; Olson, S C; Coffman, J A; Nasrallah, H A 1990. Third and lateral ventricular volumes in schizophrenia: support for progressive enlargement of both structures. Psychopharmacology bulletin, 26 3, 385-91

Nasrallah, H A 1989. Right-hemisphere speech, callosal size, perinatal brain insult, and schizophrenia. Annals of neurology, 26 2, 290-1

Nasrallah, H A; Coffman, J A; Olson, S C 1989. Structural brain-imaging findings in affective disorders: an overview. The Journal of neuropsychiatry and clinical neurosciences, 1 1, 21-6

Schwarzkopf, S B; Nasrallah, H A; Olson, S C; Coffman, J A; McLaughlin, J A 1989. Perinatal complications and genetic loading in schizophrenia: preliminary findings. Psychiatry research, 27 3, 233-9

Nasrallah, H A; Churchill, C M; Hamdan-Allan, G A 1988. Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia. The American journal of psychiatry, 145 11, 1455-6

Schwarzkopf, S B; Chapman, R M; Jimenez, M; Treglia, L; Kane, C F; Lamberti, J S; Nasrallah, H A 1988. Familial and sporadic schizophrenia: visual evoked potential differences. Biological psychiatry, 24 7, 828-33

Burns, E M; Nasrallah, H A; Kathol, M H; Kruckeberg, T W; Coffman, J A 1987. Right vs. left hemispheric blood-brain barrier permeability in schizophrenia: a dynamic computed tomographic study. Psychiatry research, 22 3, 229-41

Coffman, J A; Nasrallah, H A; Lyskowski, J; McCalley-Whitters, M; Dunner, F J 1987. Clinical effectiveness of oral and parenteral rapid neuroleptization. The Journal of clinical psychiatry, 48 1, 20-4

Coffman, J A; Nasrallah, H A; Olson, S C 1987. Differences between schizophrenics and controls in CT-measured radiodensity of samples from the anterior corpus callosum. Acta psychiatrica Scandinavica, 75 4, 446

Wilcox, J A; Nasrallah, H A 1987. Childhood head trauma and psychosis. Psychiatry research, 21 4, 303-6

Wilcox, J A; Nasrallah, H A 1987. Perinatal distress and prognosis of psychotic illness. Neuropsychobiology, 17 4, 173-5

Wilcox, J A; Nasrallah, H A 1987. Perinatal insult as a risk factor in paranoid and nonparanoid schizophrenia. Psychopathology, 20 5-6, 285-7

Andreasen, N; Nasrallah, H A; Dunn, V; Olson, S C; Grove, W M; Ehrhardt, J C; Coffman, J A; Crossett, J H 1986. Structural abnormalities in the frontal system in schizophrenia. A magnetic resonance imaging study. Archives of general psychiatry, 43 2, 136-44

D'Mello, D A; Nasrallah, H A 1986. Suppression of tardive dyskinesia with amoxapine: case report. The Journal of clinical psychiatry, 47 3, 148

Lewis, D A; Nasrallah, H A 1986. Mania associated with electroconvulsive therapy. The Journal of clinical psychiatry, 47 7, 366-7

Nasrallah, H A; Andreasen, N C; Coffman, J A; Olson, S C; Dunn, V D; Ehrhardt, J C; Chapman, S M 1986. A controlled magnetic resonance imaging study of corpus callosum thickness in schizophrenia. Biological psychiatry, 21 3, 274-82

Nasrallah, H A; Dunner, F J; McCalley-Whitters, M; Smith, R E 1986. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management. The Journal of clinical psychiatry, 47 2, 56-9

Nasrallah, H A; Loney, J; Olson, S C; McCalley-Whitters, M; Kramer, J; Jacoby, C G 1986. Cortical atrophy in young adults with a history of hyperactivity in childhood. Psychiatry research, 17 3, 241-6

Nasrallah, H A; Olson, S C; McCalley-Whitters, M; Chapman, S; Jacoby, C G 1986. Cerebral ventricular enlargement in schizophrenia. A preliminary follow-up study. Archives of general psychiatry, 43 2, 157-9

Nasrallah, H A; Varney, N; Coffman, J A; Bayless, J; Chapman, S 1986. Opiate antagonism fails to reverse post-ECT cognitive deficits. The Journal of clinical psychiatry, 47 11, 555-6

Wilcox, J A; Nasrallah, H A 1986. Organic factors in catatonia. The British journal of psychiatry : the journal of mental science, 149 , 782-4

Wilcox, J A; Nasrallah, H A 1986. Sydenham's chorea and psychosis. Neuropsychobiology, 15 1, 13-4

Coffman, J A; Nasrallah, H A 1985. Relationships between brain density, cortical atrophy and ventriculomegaly in schizophrenia and mania. Acta psychiatrica Scandinavica, 72 2, 126-32

Coffman, J A; Olshansky, B; Nasrallah, H A; Skorton, D; Chapman, S 1985. Echocardiographic assessment of schizophrenics and manics: a reexamination of early necropsy findings. The Journal of nervous and mental disease, 173 3, 179-81

Jaeckle, R S; Nasrallah, H A 1985. Major depression and carbon monoxide-induced parkinsonism: diagnosis, computerized axial tomography, and response to L-dopa. The Journal of nervous and mental disease, 173 8, 503-8

Kronfol, Z; Nasrallah, H A; Chapman, S; House, J D 1985. Depression, cortisol metabolism and lymphocytopenia. Journal of affective disorders, 9 2, 169-73

Nasrallah, H A; Dunner, F J; McCalley-Whitters, M 1985. A placebo-controlled trial of valproate in tardive dyskinesia. Biological psychiatry, 20 2, 205-8

Nasrallah, H A; Jacoby, C G; Chapman, S; McCalley-Whitters, M 1985. Third ventricular enlargement on CT scans in schizophrenia: association with cerebellar atrophy. Biological psychiatry, 20 4, 443-50

Nasrallah, H A; Varney, N; Coffman, J A; Bayless, J; Chapman, S 1985. Effects of naloxone on cognitive deficits following electroconvulsive therapy. Psychopharmacology bulletin, 21 1, 89-90

Rogers, K L; Nasrallah, H A 1985. ECT was found to be effective in remitting the symptoms of late onset diabetes mellitus. Acta psychiatrica Scandinavica, 72 4, 402

Coffman, J A; Andreasen, N C; Nasrallah, H A 1984. Left hemispheric density deficits in chronic schizophrenia. Biological psychiatry, 19 8, 1237-47

Coffman, J A; Nasrallah, H A 1984. Statistical "noise" in CAT scan measurements. The American journal of psychiatry, 141 10, 1311-2

Coffman, J A; Nasrallah, H A 1984. Brain density patterns in schizophrenia and mania. Journal of affective disorders, 6 3-4, 307-15

Nasrallah, H A; Dunner, F J; Smith, R E; McCalley-Whitters, M; Sherman, A D 1984. Variable clinical response to choline in tardive dyskinesia. Psychological medicine, 14 3, 697-700

Nasrallah, H A; McCalley-Whitters, M 1984. Seasonality of birth in subtypes of chronic schizophrenia. Acta psychiatrica Scandinavica, 69 4, 292-5

Nasrallah, H A; McCalley-Whitters, M; Chapman, S 1984. Cerebral ventricular enlargement and suicide in schizophrenia and mania. The American journal of psychiatry, 141 7, 919

Nasrallah, H A; McCalley-Whitters, M; Pfohl, B 1984. Clinical significance of large cerebral ventricles in manic males. Psychiatry research, 13 2, 151-6

Tsai, L Y; Nasrallah, H A; Jacoby, C G 1984. Cerebral asymmetry in subtypes of schizophrenia. The Journal of clinical psychiatry, 45 10, 423-5

Wilson, R L; Waziri, R; Nasrallah, H A; McCalley-Whitters, M 1984. The lateralization of tardive dyskinesia. Biological psychiatry, 19 4, 629-35

Alexander, B; Nasrallah, H A; Perry, P J; Liskow, B I; Dunner, F J 1983. The impact of psychopharmacology education on prescribing practices. Hospital & community psychiatry, 34 12, 1150-3

Bigelow, L B; Nasrallah, H A; Rauscher, F P 1983. Corpus callosum thickness in chronic schizophrenia. The British journal of psychiatry : the journal of mental science, 142 , 284-7

Hamra, B J; Nasrallah, H A; Clancy, J; Finn, R 1983. Psychiatric diagnosis and risk for tardive dyskinesia. Archives of general psychiatry, 40 3, 346-7

McCalley-Whitters, M; Nasrallah, H A 1983. Tardive dyskinesia in a phantom limb. The British journal of psychiatry : the journal of mental science, 142 , 206-7

Nasrallah, H A; Keelor, K; McCalley-Whitters, M 1983. Laterality shift in alcoholic males. Biological psychiatry, 18 9, 1065-7

Nasrallah, H A; Kuperman, S; Hamra, B J; McCalley-Whitters, M 1983. Clinical differences between schizophrenic patients with and without large cerebral ventricles. The Journal of clinical psychiatry, 44 11, 407-9

Nasrallah, H A; Kuperman, S; Jacoby, C G; McCalley-Whitters, M; Hamra, B 1983. Clinical correlates of sulcal widening in chronic schizophrenia. Psychiatry research, 10 4, 237-42

Nasrallah, H A; McCalley-Whitters, M; Bigelow, L B; Rauscher, F P 1983. A histological study of the corpus callosum in chronic schizophrenia. Psychiatry research, 8 4, 251-60

Nasrallah, H A; Tippin, J; McCalley-Whitters, M 1983. Neurological soft signs in manic patients. A comparison with Schizophrenic and control groups. Journal of affective disorders, 5 1, 45-50

Singh, M M; Becker, R E; Pitman, R K; Nasrallah, H A; Lal, H 1983. Sustained improvement in tardive dyskinesia with diazepam: indirect evidence for corticolimbic involvement. Brain research bulletin, 11 2, 179-85

Tsai, L Y; Nasrallah, H A; Jacoby, C G 1983. Hemispheric asymmetries on computed tomographic scans in schizophrenia and mania. A controlled study and a critical review. Archives of general psychiatry, 40 12, 1286-9

Lyskowski, J; Nasrallah, H A; Dunner, F J; Bucher, K 1982. A longitudinal survey of side effects in a lithium clinic. The Journal of clinical psychiatry, 43 7, 284-6

Nasrallah, H A 1982. Neuropathology of the corpus callosum in schizophrenia. The British journal of psychiatry : the journal of mental science, 141 , 99-100

Nasrallah, H A 1982. Hemispheric asymmetry in affective disorders. Psychopharmacology bulletin, 18 2, 62-7

Nasrallah, H A; Coryell, W H 1982. Dexamethasone nonsuppression predicts the antidepressant effects of sleep deprivation. Psychiatry research, 6 1, 61-64

Nasrallah, H A; Jacoby, C G; McCalley-Whitters, M; Kuperman, S 1982. Cerebral ventricular enlargement in subtypes of chronic schizophrenia. Archives of general psychiatry, 39 7, 774-7

Nasrallah, H A; Lyskowksi, J; Schroeder, D 1982. TCA-induced mania: differences between switchers and nonswitchers. Biological psychiatry, 17 2, 271-4

Nasrallah, H A; McCalley-Whitters, M 1982. Motor lateralization in manic males. The British journal of psychiatry : the journal of mental science, 140 , 521-2

Nasrallah, H A; McCalley-Whitters, M; Jacoby, C G 1982. Cortical atrophy in schizophrenia and mania: a comparative CT study. The Journal of clinical psychiatry, 43 11, 439-41

Nasrallah, H A; McCalley-Whitters, M; Jacoby, C G 1982. Cerebral ventricular enlargement in young manic males. A controlled CT study. Journal of affective disorders, 4 1, 15-9

Nasrallah, H A; McCalley-Whitters, M; Kuperman, S 1982. Neurological differences between paranoid and nonparanoid schizophrenia: part I. sensory-motor lateralization. The Journal of clinical psychiatry, 43 8, 305-6

Nasrallah, H A; Rizzo, M; Damasio, H; McCalley-Whitters, M; Kuperman, S; Jacoby, C G 1982. Neurological differences between paranoid and nonparanoid schizophrenia: part II. computerized tomographic findings. The Journal of clinical psychiatry, 43 8, 307-9

Nasrallah, H A; Schroeder, D; Petty, F 1982. Alcoholism secondary to essential tremor. The Journal of clinical psychiatry, 43 4, 163-4

Nasrallah, H A; Smith, R E; Dunner, F J; McCalley-Whitters, M 1982. Serotonin precursor effects in tardive dyskinesia. Psychopharmacology, 77 3, 234-5

Nasrallah, H A; Tippin, J; McCalley-Whitters, M; Kuperman, S 1982. Neurological differences between paranoid and nonparanoid schizophrenia: part III. neurological soft signs. The Journal of clinical psychiatry, 43 8, 310-2

Schroeder, D; Nasrallah, H A 1982. High alcoholism rate in patients with essential tremor. The American journal of psychiatry, 139 11, 1471-3

Singh, M M; Becker, R E; Pitman, R K; Nasrallah, H A; Lal, H; Dufresne, R L; Weber, S S; McCalley-Whitters, M 1982. Diazepam-induced changes in tardive dyskinesia: suggestions for a new conceptual model. Biological psychiatry, 17 6, 729-42

Lyskowski, J; Nasrallah, H A 1981. Slowed release lithium: a review and a comparative study. Journal of clinical psychopharmacology, 1 6, 406-8

Lyskowski, J; Nasrallah, H A 1981. Lithium therapy and the risk for leukemia. The British journal of psychiatry : the journal of mental science, 139 , 256

Nasrallah, H A; Fowler, R C; Judd, L L 1981. Schizophrenia-like illness following head injury. Psychosomatics, 22 4, 359-61

Nasrallah, H A; Jacoby, C G; McCalley-Whitters, M 1981. Cerebellar atrophy in schizophrenia and mania. Lancet, 1 8229, 1102

Nasrallah, H A; Keelor, K; Van Schroeder, C; Whitters, M M 1981. Motoric lateralization in schizophrenic males. The American journal of psychiatry, 138 8, 1114-5

Nasrallah, H A; McChesney, C M 1981. Psychopathology of corpus callosum tumors. Biological psychiatry, 16 7, 663-9

Freed, W J; Nasrallah, H A; Rogol, A D; Wyatt, R J 1980. Propranolol in high doses increases plasma prolactin concentrations in male rats. Biological psychiatry, 15 2, 311-7

Nasrallah, H A 1980. Neuroleptic plasma levels and tardive dyskinesia: a possible link? Schizophrenia bulletin, 6 1, 4-7

Nasrallah, H A; Kleinman, J E; Weinberger, D R; Gillin, J C; Wyatt, R J 1980. Cerebral ventricular enlargement and dopamine synthesis inhibition in chronic schizophrenia. Archives of general psychiatry, 37 12, 1427-

Nasrallah, H A; Kuperman, S; Coryell, W 1980. Reversal of dexamethasone nonsuppression with sleep deprivation in primary depression. The American journal of psychiatry, 137 11, 1463-4

Nasrallah, H A; Pappas, N J; Crowe, R R 1980. Oculogyric dystonia in tardive dyskinesia. The American journal of psychiatry, 137 7, 850-1

Rauscher, F P; Nasrallah, H A; Wyatt, R J 1980. Cutaneous histamine response in schizophrenia. The Journal of clinical psychiatry, 41 2, 44-51

Smith, R E; Low, N N; Nasrallah, H A 1980. Haloperidol and an unrelated sudden death. The American journal of psychiatry, 137 7, 843-4

Kleinman, J E; Potkin, S; Rogol, A; Buchsbaum, M S; Murphy, D L; Gillin, J C; Nasrallah, H A; Wyatt, R J 1979. A correlation between platelet monoamine oxidase activity and plasma prolactin concentrations in man. Science (New York, N.Y.), 206 4417, 479-81

Nasrallah, H A 1979. Tardive dyskinesia symptoms. Psychopharmacology bulletin, 15 4, 5-6

Nasrallah, H A 1979. Vulnerability to disulfiram psychosis. The Western journal of medicine, 130 6, 575-7

Nasrallah, H A 1979. Tardive dyskinesia and depot fluphenazine. The British journal of psychiatry : the journal of mental science, 134 , 550

Nasrallah, H A 1979. Methodological issues in tardive dyskinesia research. Schizophrenia bulletin, 5 1, 1-2

Nasrallah, H A; Holley, T; Janowsky, D S 1979. Opiate antagonism fails to reverse hypnotic-induced analgesia. Lancet, 1 8130, 1355

Nasrallah, H A; Risch, S C; Fowler, R C 1979. Reserpine, serotonin, and schizophrenia. The American journal of psychiatry, 136 6, 856-7

Carman, J S; Wyatt, R J; Nasrallah, H A; O'Brien, P; Gillin, J C 1978. Weight change during various neuropharmacologic manipulations in psychotic inpatients. Acta científica venezolana, 29 3, 178-80

Donnelly, E F; Nasrallah, H A; Wyatt, R J; Gillin, J C; Bigelow, L B 1978. Effects of dopamine synthesis inhibition on WAIS comprehension. Journal of consulting and clinical psychology, 46 3, 385-8

Nasrallah, H A 1978. Factors influencing phenothiazine-induced ECG changes. The American journal of psychiatry, 135 1, 118-9

Nasrallah, H A; Rivera-Calimlin, L; Rogol, A D 1978. Fluphenazine decanoate: plasma concentrations and clinical response [proceedings] Psychopharmacology bulletin, 14 3, 46-7

Potkin, S G; Gillin, J C; Rogol, A; Nasrallah, H A; Wyatt, R J 1978. Baclofen: lack of effect on human plasma prolactin. Communications in psychopharmacology, 2 4, 297-300

Rivera-Calimlim, L; Gift, T; Nasrallah, H A; Wyatt, R J; Lasagna, L 1978. Correlation between plasma concentrations of chlorpromazine and clinical response. Communications in psychopharmacology, 2 3, 215-22

Nasrallah, H A; Donnelly, E F; Bigelow, L B; Rivera-Calimlim, L; Rogol, A; Potkin, S; Rauscher, F P; Wyatt, R J 1977. Inhibition of dopamine synthesis in chronic schizophrenia. Clinical ineffectiveness of metyrosine. Archives of general psychiatry, 34 6, 649-55

Nasrallah, H A; Freed, W J; Rogol, A; Wyatt, R J 1977. Propranolol and prolactin. Lancet, 2 8049, 1175-6

Coffman, J A; Schwarzkopf, S B; Olson, S C; Nasrallah, H A . Midsagittal cerebral anatomy by magnetic resonance imaging. The importance of slice position and thickness. Schizophrenia research, 2 3, 287-94

Gianfrancesco, Frank; Wang, Ruey-Hua; Nasrallah, Henry A . The influence of study design on the results of pharmacoepidemiologic studies of diabetes risk with antipsychotic therapy. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 18 1, 9-17

Glick, Ira D; Salzman, Carl; Cohen, Bruce M; Klein, Donald F; Moutier, Christine; Nasrallah, Henry A; Ongur, Dost; Wang, Po; Zisook, Sidney . Improving the pedagogy associated with the teaching of psychopharmacology. Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry, 31 3, 211-7

Jeste, Dilip V; Nasrallah, Henry A . Schizophrenia and aging: no more dearth of data? The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 11 6, 584-7

Nasrallah, H A . The unintegrated right cerebral hemispheric consciousness as alien intruder: a possible mechanism for Schneiderian delusions in schizophrenia. Comprehensive psychiatry, 26 3, 273-82

Nasrallah, Henry A . Focus on lower risk of tardive dyskinesia with atypical antipsychotics. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 18 1, 57-62

Nasrallah, Henry A; White, Thantween; Nasrallah, Amelia T . Lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol: preliminary analysis of retrospective data. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 12 4, 437-9

Petty, F; Nasrallah, H A . Secondary depression in alcoholism: implications for future research. Comprehensive psychiatry, 22 6, 587-95

Ramaswamy, Krishnan; Masand, Prakash S; Nasrallah, Henry A . Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 18 3, 183-94

Rosenberger, P H; Bornstein, R A; Nasrallah, H A; Para, M F; Whitaker, C C; Fass, R J; Rice, R R . Psychopathology in human immunodeficiency virus infection: lifetime and current assessment. Comprehensive psychiatry, 34 3, 150-8